IRWD FY 2013 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$600M

FY 2013 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$23M-84.8% YoY

Gross Profit

$16M68.5% margin

Operating Income

-$252M-1101.4% margin

Net Income

-$273M-1192.3% margin

EPS (Diluted)

$-2.35

Cash Flow

Operating Cash Flow

-$273M

Free Cash Flow

-$283M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$279M

Total Liabilities

$241M

Stockholders' Equity

$38M

Cash & Equivalents

$75M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$150M	-84.8%
Gross Profit	$16M	$149M	-89.5%
Operating Income	-$252M	-$73M	-246.3%
Net Income	-$273M	-$73M	-275.6%